PCM
TMDX icon

Prelude Capital Management’s Transmedics TMDX Stock Holding History

Prelude Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,586
Closed -$257K – 1533
2026
Q1 		$257K Buy
2,586
+541
+26% +$70.6K 0.02% 782
2025
Q4 		$249K Buy
+2,045
New +$257K 0.02% 897
2024
Q1 		– Sell
-2,874
Closed -$227K – 1522
2023
Q4 		$227K Buy
+2,874
New +$173K 0.02% 884
2019
Q4 		– Sell
-9,572
Closed -$227K – 2249
2019
Q3 		$227K Buy
9,572
+1,750
+22% +$42K 0.01% 733
2019
Q2 		$227K Buy
+7,822
New +$214K 0.01% 694

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Prelude Capital Management's TMDX Position: Q2 2026 in Review

Prelude Capital Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,586 shares — an estimated $257K sold.

Prelude Capital Management first reported a position in TMDX in Q2 2019 and held it in 5 quarters. The position peaked at $257K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Prelude Capital Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 2,586 Transmedics shares in Q2 2026, an estimated $257K.
  • Prelude Capital Management first reported a position in Transmedics in Q2 2019 and held it in 5 quarters.
  • Prelude Capital Management's Transmedics position peaked at $257K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.